Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Melanoma epidemiology and trends.
Garbe C, Leiter U. Garbe C, et al. Among authors: leiter u. Clin Dermatol. 2009 Jan-Feb;27(1):3-9. doi: 10.1016/j.clindermatol.2008.09.001. Clin Dermatol. 2009. PMID: 19095149
Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma.
Leiter U, Schmid RM, Kaskel P, Peter RU, Krähn G. Leiter U, et al. Arch Dermatol Res. 2000 May;292(5):225-32. doi: 10.1007/s004030050479. Arch Dermatol Res. 2000. PMID: 10867810
Fulminating multi-organ failure in a young woman caused by rapidly progressing melanoma metastases.
Kaskel P, Orth M, Arndt E, Leiter U, Peter RU, Krähn G. Kaskel P, et al. Among authors: leiter u. Dermatology. 2000;201(1):79-80. doi: 10.1159/000018442. Dermatology. 2000. PMID: 10971073 No abstract available.
Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
Kraehn GM, Utikal J, Udart M, Greulich KM, Bezold G, Kaskel P, Leiter U, Peter RU. Kraehn GM, et al. Among authors: leiter u. Br J Cancer. 2001 Jan 5;84(1):72-9. doi: 10.1054/bjoc.2000.1535. Br J Cancer. 2001. PMID: 11139316 Free PMC article.
Expression of c-myc and bcl-2 in primary and advanced cutaneous melanoma.
Utikal J, Leiter U, Udart M, Kaskel P, Peter RU, Krähn GM. Utikal J, et al. Among authors: leiter u. Cancer Invest. 2002;20(7-8):914-21. doi: 10.1081/cnv-120005904. Cancer Invest. 2002. PMID: 12449722
Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients.
Garbe C, Leiter U, Ellwanger U, Blaheta HJ, Meier F, Rassner G, Schittek B. Garbe C, et al. Among authors: leiter u. Cancer. 2003 Apr 1;97(7):1737-45. doi: 10.1002/cncr.11250. Cancer. 2003. PMID: 12655531
The natural course of cutaneous melanoma.
Leiter U, Meier F, Schittek B, Garbe C. Leiter U, et al. J Surg Oncol. 2004 Jul 1;86(4):172-8. doi: 10.1002/jso.20079. J Surg Oncol. 2004. PMID: 15221923 Review.
Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
Leiter U, Buettner PG, Eigentler TK, Garbe C. Leiter U, et al. J Clin Oncol. 2004 Sep 15;22(18):3660-7. doi: 10.1200/JCO.2004.03.074. Epub 2004 Aug 9. J Clin Oncol. 2004. PMID: 15302905
Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
Eigentler TK, Buettner PG, Leiter U, Garbe C; Central Malignant Melanoma Registry of the German Dermatological Society. Eigentler TK, et al. Among authors: leiter u. J Clin Oncol. 2004 Nov 1;22(21):4376-83. doi: 10.1200/JCO.2004.03.075. J Clin Oncol. 2004. PMID: 15514379
Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG, Leiter U, Eigentler TK, Garbe C. Buettner PG, et al. Among authors: leiter u. Cancer. 2005 Feb 1;103(3):616-24. doi: 10.1002/cncr.20816. Cancer. 2005. PMID: 15630700
125 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback